Longevity Biotech Company
Longevity Biotech, a Philadelphia, PA-based developer of a new class of therapeutics via artificial protein technology. Longevity Biotech focuses on pharmaceutical preparation. Its hybridtides are targeted biologic-like molecules which are highly-resistant to breakdown by natural digestive enzymesand tunable to very stable molecular structures.
Last Funding Type:
Grant
Headquarters:
United States
Founded Date:
2010
Investor Type:
Company
Total Funding:
$836.4K
Technology:
Metabolic Disorders
Employee Number:
1-10
Number Of Exists:
Grant
Estimated Revenue:
Less than $1M
Investors Number:
2
Industry:
Energetic Process